Tsutomu Nishizawa Selected Research

Tsutomu Nishizawa Research Topics

Disease

14	Infections 02/2022 - 09/2002
8	Hepatitis E 10/2019 - 02/2003
8	Hepatitis 02/2017 - 09/2002
6	Massive Hepatic Necrosis 11/2017 - 07/2005
3	Hepatitis A (Hepatitis, Infectious) 02/2017 - 03/2004
3	Hepatocellular Carcinoma (Hepatoma) 10/2016 - 02/2005
3	Moyamoya Disease (Moya-Moya Disease) 03/2011 - 12/2010
3	Hepatitis B 05/2006 - 02/2003
3	Viremia 08/2005 - 03/2004
2	Chronic Hepatitis C 05/2022 - 09/2011
2	Hepatic Encephalopathy 02/2017 - 07/2005
2	Coinfection 12/2005 - 02/2003
1	Falciparum Malaria (Plasmodium falciparum Malaria) 05/2022
1	Persistent Infection 05/2022
1	Chronic Hepatitis (Chronic Active Hepatitis) 10/2019
1	Communicable Diseases (Infectious Diseases) 11/2017
1	Acute Liver Failure (Fulminant Hepatic Failure) 02/2017
1	Esophageal Neoplasms (Esophageal Cancer) 04/2015
1	Diabetes Mellitus 04/2015
1	Heart Failure 06/2014
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 11/2013
1	Congenital Heart Defects (Congenital Heart Defect) 01/2012
1	Thoracic Aortic Aneurysm 03/2011
1	Schinzel-Giedion syndrome 02/2011
1	Fibrosis (Cirrhosis) 02/2011
1	Epilepsy (Aura) 01/2011
1	Intellectual Disability (Idiocy) 01/2011
1	Persistent Truncus Arteriosus 08/2009
1	Noonan Syndrome (Female Pseudo-Turner Syndrome) 08/2007
1	Superinfection 05/2006
1	Hemophilia A (Haemophilia) 05/2005
1	HIV Infections (HIV Infection) 05/2005
1	Liver Cirrhosis (Hepatic Cirrhosis) 02/2005

Drug/Important Bio-Agent (IBA)

13	RNA (Ribonucleic Acid)IBA 10/2016 - 09/2002
10	AntibodiesIBA 01/2017 - 09/2002
8	NucleotidesIBA 10/2019 - 04/2006
7	Immunoglobulin M (IgM)IBA 05/2006 - 09/2002
5	Immunoglobulin G (IgG)IBA 01/2017 - 02/2003
5	Hepatitis B Surface Antigens (HBsAg)FDA Link 04/2015 - 02/2003
5	EnzymesIBA 07/2005 - 09/2002
4	Proteins (Proteins, Gene)FDA Link 10/2016 - 01/2005
3	AntigensIBA 06/2016 - 01/2005
3	DNA (Deoxyribonucleic Acid)IBA 02/2011 - 05/2005
3	Immunoglobulin A (IgA)IBA 08/2005 - 02/2003
2	Circular DNAIBA 02/2022 - 03/2020
2	Ribavirin (Virazole)FDA LinkGeneric 10/2019 - 01/2019
2	Antiviral Agents (Antivirals)IBA 01/2019 - 04/2015
2	Carrier Proteins (Binding Protein)IBA 11/2013 - 02/2011
2	BilirubinIBA 07/2005 - 09/2002
2	ImmunosorbentsIBA 07/2005 - 12/2004
2	Alanine Transaminase (SGPT)IBA 08/2004 - 09/2002
1	glecaprevir and pibrentasvirIBA 05/2022
1	Interferon-alpha (Interferon Alfa)IBA 10/2019
1	SofosbuvirIBA 10/2019
1	InterferonsIBA 01/2019
1	LipidsIBA 11/2017
1	Transaminases (Aminotransferases)IBA 02/2017
1	Messenger RNA (mRNA)IBA 10/2016
1	Hepatitis B e AntigensIBA 10/2016
1	Sirolimus (Rapamycin)FDA Link 06/2014
1	Cardiac MyosinsIBA 11/2013
1	Troponin T (Troponin T1)IBA 11/2013
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 11/2013
1	Transcription Factors (Transcription Factor)IBA 01/2012
1	5' Untranslated Regions (5' UTR)IBA 09/2011
1	1,3,4,6- tetra- O- acetyl- 2- azido- 2- deoxyglucopyranose (TAAD)IBA 03/2011
1	Protein Isoforms (Isoforms)IBA 03/2011
1	ElastinIBA 02/2011
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 12/2010
1	GATA6 Transcription FactorIBA 08/2009
1	Phosphotransferases (Kinase)IBA 08/2007
1	MorpholinosIBA 08/2007
1	Immunoglobulin IsotypesIBA 07/2005
1	Prothrombin (Factor II)IBA 07/2005
1	Hepatitis delta Antigens (HDAg)IBA 07/2005

Therapy/Procedure

2	Organ Transplantation 11/2017 - 04/2015
2	Blood Transfusion (Blood Transfusions) 12/2004 - 07/2003
1	Plasma Exchange 05/2022
1	Critical Care (Surgical Intensive Care) 02/2017
1	Renal Dialysis (Hemodialysis) 12/2004